These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 7426922

  • 41. [Radiotherapy in combination with misonidazole and ACNU in lung neoplasms].
    Asakura H, Maruhashi A, Mashima Y, Kanazawa A.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Nov 25; 43(11):1295-306. PubMed ID: 6584857
    [No Abstract] [Full Text] [Related]

  • 42. Misonidazole in fractionated radiotherapy of a murine mammary carcinoma: comparison of tumor and normal tissue response.
    Stone HB.
    Int J Radiat Oncol Biol Phys; 1988 May 25; 14(5):957-62. PubMed ID: 3360661
    [Abstract] [Full Text] [Related]

  • 43. Misonidazole-a drug for trial in radiotherapy and oncology.
    Dische S, Saunders MI, Flockhart IR, Lee ME, Anderson P.
    Int J Radiat Oncol Biol Phys; 1979 Jun 25; 5(6):851-60. PubMed ID: 227822
    [No Abstract] [Full Text] [Related]

  • 44. Effect of misonidazole on the tolerance of the rat spinal cord to daily and multiple fractions per day of X rays.
    van der Kogel AJ, Sissingh HA.
    Br J Radiol; 1983 Feb 25; 56(662):121-5. PubMed ID: 6824830
    [Abstract] [Full Text] [Related]

  • 45. Cytotoxicity of misonidazole in vivo under conditions of prolonged contact of drug with the tumour cells.
    Brown JM, Yu NY.
    Br J Radiol; 1979 Nov 25; 52(623):893-6. PubMed ID: 519148
    [Abstract] [Full Text] [Related]

  • 46. Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer.
    Wasserman TH, Phillips TL, Johnson RJ, Gomer CJ, Lawrence GA, Sadee W, Marques RA, Levin VA, VanRaalte G.
    Int J Radiat Oncol Biol Phys; 1979 Jun 25; 5(6):775-86. PubMed ID: 227821
    [No Abstract] [Full Text] [Related]

  • 47. Interstitial misonidazole. A preliminary report on a new perspective in clinical radiation sensitization and hypoxic cell chemotherapy.
    Sealy R, Korrubel J, Cridland S, Blekkenhorst G.
    Cancer; 1984 Oct 15; 54(8):1535-40. PubMed ID: 6478394
    [Abstract] [Full Text] [Related]

  • 48. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations.
    Grdina DJ, Sigdestad CP, Jovonovich JA.
    Cancer Clin Trials; 1980 Oct 15; 3(2):149-54. PubMed ID: 7428138
    [Abstract] [Full Text] [Related]

  • 49. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of grades 3 and 4 astrocytomas. A report from the MRC Working Party on misonidazole in gliomas.
    Br J Radiol; 1983 Sep 15; 56(669):673-82. PubMed ID: 6309314
    [Abstract] [Full Text] [Related]

  • 50. Misonidazole dose and tumor level relationships. Effects of individual variation in rate of misonidazole metabolism and absorption from the gastrointestinal tract.
    Strong JM, Schwade JG, Gangji D, Shoemaker DD, Upton DK.
    Cancer Clin Trials; 1981 Sep 15; 4(1):41-6. PubMed ID: 7214661
    [No Abstract] [Full Text] [Related]

  • 51. Misonidazole combined with radiotherapy in the treatment of inoperable squamous cell carcinoma of the lung. A double-blind randomized trial.
    Panduro J, Kjaer M, Wolff-Jensen J, Hansen HH.
    Cancer; 1983 Jul 01; 52(1):20-4. PubMed ID: 6303553
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. The effect of misonidazole as a hypoxic radiosensitizer at low dose.
    Palcic B, Faddegon B, Skarsgard LD.
    Radiat Res; 1984 Nov 01; 100(2):340-7. PubMed ID: 6494445
    [Abstract] [Full Text] [Related]

  • 54. Radioprotection combined with hypoxic sensitization during radiotherapy of a solid murine tumor.
    Mendiondo OA, Grigsby PW, Beach JL.
    Radiology; 1983 Jul 01; 148(1):291-3. PubMed ID: 6304811
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Evaluation of the bioavailability of misonidazole (NSC#261037) in capsule and tablet form and pharmacologic effects of daily dosage.
    VanRaalte G, Phillips TL, Wasserman TH.
    Int J Radiat Oncol Biol Phys; 1982 Feb 01; 8(2):279-82. PubMed ID: 7085383
    [Abstract] [Full Text] [Related]

  • 59. Review: total doses in fractionated radiotherapy--implications of new radiobiological data.
    Fowler JF.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1984 Aug 01; 46(2):103-20. PubMed ID: 6381354
    [Abstract] [Full Text] [Related]

  • 60. Hypoxic-cell sensitisers.
    Karim AB.
    Lancet; 1978 Oct 21; 2(8095):891-2. PubMed ID: 81431
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.